Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Johnson DB, Nebhan CA, Moslehi JJ, et al. Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol. 2022;19(4):254–67. https://doi.org/10.1038/s41571-022-00600-w.

Article  PubMed  PubMed Central  Google Scholar 

Hegde PS, Karanikas V, Evers S. The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition. Clin Cancer Res. 2016;22(8):1865–74. https://doi.org/10.1158/1078-0432.CCR-15-1507.

Article  CAS  PubMed  Google Scholar 

Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol. 2021;16:223–49. https://doi.org/10.1146/annurev-pathol-042020-042741.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Lou Y, Wang J, et al. Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment. Front Immunol. 2021;11:609705. https://doi.org/10.3389/fimmu.2020.609705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia Y, Sun J, Zhao Y, et al. Chinese patent medicine for osteoporosis: a systematic review and meta-analysis. Bioengineered. 2022;13(3):5581–97. https://doi.org/10.1080/21655979.2022.2038941.

Article  PubMed  PubMed Central  Google Scholar 

Li R, Chen H, Feng J, et al. Effectiveness of traditional Chinese exercise for symptoms of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Int J Environ Res Public Health. 2020;17(21):7873. https://doi.org/10.3390/ijerph17217873.

Article  PubMed  PubMed Central  Google Scholar 

Schlaeger JM, Stoffel CL, Bussell JL, et al. Moxibustion for cephalic version of breech presentation. J Midwifery Womens Health. 2018;63(3):309–22. https://doi.org/10.1111/jmwh.12752.

Article  PubMed  Google Scholar 

Hsiao WL, Liu L. The role of traditional Chinese herbal medicines in cancer therapy–from TCM theory to mechanistic insights. Planta Med. 2010;76(11):1118–31. https://doi.org/10.1055/s-0030-1250186.

Article  CAS  PubMed  Google Scholar 

Jia L, Ma S, Hou X, et al. The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment. Oncol Lett. 2013;5(5):1439–47. https://doi.org/10.3892/ol.2013.1245.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng W, Cheng Z, Xing D, Zhang M. Asparagus polysaccharide suppresses the migration, invasion, and angiogenesis of hepatocellular carcinoma cells partly by targeting the HIF-1α/VEGF signalling pathway in vitro. Evid Based Complement Alternat Med. 2019;2019:3769879. https://doi.org/10.1155/2019/3769879.

Article  PubMed  PubMed Central  Google Scholar 

Li J, Yu Y, Cai J, et al. Chinese medicine dictionary. Beijing: People’s Medical Publishing House; 2005.

Google Scholar 

Wang B, Dong X. Chinese-english bilingual glossary of traditional Chinese medicine. Beijing: Science Press; 1993.

Google Scholar 

Chen H, Li S, Cho W, et al. The role of acupoint stimulation as an adjunct therapy for lung cancer: a systematic review and meta-analysis. BMC Complement Altern Med. 2013;13:362. https://doi.org/10.1186/1472-6882-13-362.

Article  PubMed  PubMed Central  Google Scholar 

Cao X. Immunology in China: the past, present and future. Nat Immunol. 2008;9(4):339–42. https://doi.org/10.1038/ni0408-339.

Article  CAS  PubMed  Google Scholar 

Zhang N, Xiao X. Integrative medicine in the era of cancer immunotherapy: challenges and opportunities. J Integr Med. 2021;19(4):291–4. https://doi.org/10.1016/j.joim.2021.03.005.

Article  PubMed  Google Scholar 

Wang Y, Zhang X, Wang Y, et al. Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development. Acta Pharm Sin B. 2021;11(10):2957–72. https://doi.org/10.1016/j.apsb.2021.03.004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Wang S, Zhang Y, et al. Traditional Chinese medicine and cancer: history, present situation, and development. Thorac Cancer. 2015;6(5):561–9. https://doi.org/10.1111/1759-7714.12270.

Article  PubMed  PubMed Central  Google Scholar 

Huang J, Kan J, Fan T, et al. Efficacy of the nourishing yin and clearing heat therapy based on traditional Chinese medicine in the prevention and treatment of radiotherapy-induced oral mucositis in nasopharyngeal carcinomas: a systematic review and meta-analysis of thirty randomized controlled trials. Evid Based Complement Alternat Med. 2022;2022:4436361. https://doi.org/10.1155/2022/4436361.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, Qiu H, Li C, et al. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021;15(5):283–98. https://doi.org/10.5582/bst.2021.01318.

Article  CAS  PubMed  Google Scholar 

Xu W, Li B, Xu M, et al. Traditional Chinese medicine for precancerous lesions of gastric cancer: a review. Biomed Pharmacother. 2022;146:112542. https://doi.org/10.1016/j.biopha.2021.112542.

Article  CAS  PubMed  Google Scholar 

Chan Y, Cheung F, Zhang C, et al. Ancient Chinese Medicine herbal formula Huanglian Jiedu decoction as a neoadjuvant treatment of chemotherapy by improving diarrhea and tumor response. Front Pharmacol. 2020;11:252. https://doi.org/10.3389/fphar.2020.00252.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang H, Li M, Du K, et al. Traditional Chinese medicine for adjuvant treatment of breast cancer: Taohong Siwu decoction. Chin Med. 2021;16(1):129. https://doi.org/10.1186/s13020-021-00539-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao X, Bu Y, Jia Q. Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future. Genes Dis. 2019;7(3):370–9. https://doi.org/10.1016/j.gendis.2019.10.016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Li JW, Qin YN, et al. Clinical observation on the effect of Chinese medicine-“TCM formula” intervention on recurrence and metastasis of triple negative breast cancer. Complement Ther Med. 2020;52:102456. https://doi.org/10.1016/j.ctim.2020.102456.

Article  PubMed  Google Scholar 

Liu J, Liu X, Ma J, et al. The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis. 2019. Biosci Rep. https://doi.org/10.1042/BSR20193319.

Huang X, Wang J, Lin W, et al. Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: a meta-analysis of 27 RCTs. Phytomedicine. 2020;67:153154. https://doi.org/10.1016/j.phymed.2019.153154.

Article  CAS  PubMed  Google Scholar 

Tsao SY. Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers. Explor Target Antitumor Ther. 2022;3(5):676–93. https://doi.org/10.1016/j.phymed.2019.153154.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nourmohammadi S, Aung TN, Cui J, et al. Effect of compound kushen injection, a natural compound mixture, and its identified chemical components on migration and invasion of colon, brain, and breast cancer cell lines. Front Oncol. 2019;9:314. https://doi.org/10.3389/fonc.2019.00314.

Article  PubMed  PubMed Central  Google Scholar 

Chen Q, Shu C, Laurence AD, et al. Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial. Gut. 2018;67(11):2006–16. https://doi.org/10.1136/gutjnl-2018-315983.

Article  CAS  PubMed  Google Scholar 

Yu Z, Guo J, Hu M, et al. Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma. ACS Nano. 2020;14(4):4816–28. https://doi.org/10.1021/acsnano.0c00708.

Article  CAS  PubMed  Google Scholar 

Wong A, Che C, Leung K. Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview. Nat Prod Rep. 2015;32(2):256–72. https://doi.org/10.1039/c4np00080c.

Article  CAS  PubMed  Google Scholar 

Yim NH, Kim YS, Chung HS. Inhibition of programmed death receptor-1/programmed death ligand-1 interactions by ginsenoside metabolites. Molecules. 2020;25(9):2068. https://doi.org/10.3390/molecules25092068.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005. https://doi.org/10.1002/14651858.CD004540.pub2.

Article  PubMed  Google Scholar 

Xiang Y, Guo Z, Zhu P, et al. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958–75. https://doi.org/10.1002/cam4.2108.

Article  PubMed  PubMed Central  Google Scholar 

Zhao H, Ren S, Yang H, et al. Peppermint essential oil: its phytochemistry, biological activity, pharmacological effect and application. Biomed Pharmacother. 2022;154:113559.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif